29

Apr

iAssay Wins AFWERX Phase 1 SBIR Award from U.S. Air Force

Innovative Program Aims to Improve Medical Testing Capabilities San Diego, CA 04/29/2021- iAssay announced this week that they have been awarded a Phase 1 SBIR (Small Business Innovation Research) Award through AFWERX.  iAssay makes a patent-protected medical device called SimpleTest™ that can interpret test results and transmit preserved imaging and quantitative results electronically from point of […]

21

Apr

The Next Step

Thanks to you, our amazing investors and supporters, we’ve completed our first WeFunder milestone, closing the early bird $200,000 investment stage on Wefunder.com/iAssay.We want to thank this entire amazing community for helping us reach this goal and for believing in what we are committed to do.We have exciting client announcements and major partnerships coming down […]

26

Mar

A Message from Our New Advisory Board Member and WeFunder Lead Investor

Meet Paul F. Rashid, MD, our new Advisory Board Member and investor. We are so fortunate to have him aboard! iAssay has an EarlyBird investment special for a short time. Visit the site for more details: www.WeFunder.com/iAssay

10

Mar

iAssay and DDTD Tag Team Against COVID-19

For Release March 8, 2021 iAssay and DDTD Tag Team Against COVID-19 San Diego— March 8, 2021 — iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU). DDTD is a mission-driven organization to develop accurate, affordable, mass-market treatments and diagnostics for low-resourced and under-served […]

03

Mar

Recording of Live Webinar and Q&A with CEO, Lonnie Adelman

We are pleased to share a recording of iAssay’s recent webinar. In this video iAssay’s Founder and CEO, Lonnie Adelman presents an overview of the medical testing industry and explains the trend to point of care testing. He then discusses the company’s breakthrough point of care product, SimpleTest™, and how this device is positioned to […]

16

Feb

Register to Attend the iAssay Zoom Webinar on March 2

Hello, I am reaching out to our investors and future investors to invite you to a Zoom Webinar to share more details about our new and exciting SimpleTest™ product ( www.WeFunder.com/iAssay ) that is completely revolutionizing the medical testing industry. Here are the details for the Webinar: When: Mar 2, 2021 12:00 PM Eastern Time […]

04

Feb

Our First Customer!

Dear investors, I am pleased to share some exciting news with you…We are no longer pre-revenue! GattaCo, makers of next generation medical diagnostics and simplified sample collection and processing, has signed a Memorandum of Understanding (MOU) with iAssay enabling engineers and scientists to work together to integrate and optimize their products to provide accurate, enhanced […]

18

Jan

INDUSTRY UPDATE: Notes from the invitation-only JP Morgan Healthcare virtual conference

During the week of January 11, 2021, JP Morgan conducted their annual healthcare conference. Having attended for several years we wanted to provide a few relevant highlights for our investors.  As a consequence of the COVID-19 pandemic there has been an increased acceptance in the use of point of care testing to determine who has […]

13

Dec

MintzTech Connect December 2020 Edition Features iAssay.

iAssay is honored to have been included in this All Things Technology issue, Industry News Spotlight. See it here: https://lnkd.in/gXtBYU3

10

Nov

GattaCo and iAssay Join Forces in COVID-19 Fight

Murrieta / San Diego— 11/10/2020 — Today GattaCo and iAssay announced that they have signed a Memorandum of Understanding (MOU), enabling engineers and scientists to work together to integrate and optimize their products in an effort to provide enhanced rapid serology testing, including COVID-19 antibody testing and electronic test result transmission to federal and state […]